Clinical application of liver stiffness measurement in patients with cavernous transformation of portal vein

Shen,Yue; Ma,Wei; Hang,Ying; Liu,Li-Li; Jiang,Wei; Wu,Sheng-Di

doi:10.3892/etm.2021.9881

Clinical application of liver stiffness measurement in patients with cavernous transformation of portal vein

Authors:
- Yue Shen
- Wei Ma
- Ying Hang
- Li-Li Liu
- Wei Jiang
- Sheng-Di Wu
View Affiliations

Affiliations: Department of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, Shanghai 200032, P.R. China, Department of Emergency, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 201204, P.R. China
Published online on: February 28, 2021 https://doi.org/10.3892/etm.2021.9881
Article Number: 442

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The clinical outcomes differ between patients with cavernous transformation of the portal vein (CTPV) with and without cirrhosis. Therefore, invasive liver biopsy may be needed for the differential diagnosis of patients with CTPV with or without cirrhosis. The present study aimed to investigate the diagnostic efficacy of liver stiffness measurements (LSM) for the prediction of cirrhosis in patients with CTPV. A total of 20 patients with CTPV, 34 with chronic hepatitis B (CHB)‑related cirrhosis and 20 healthy volunteers, were retrospectively recruited in the study. CTPV was diagnosed with contrast‑enhanced computed tomography (CT) and ultrasound for the abdomen. LSM values were detected for each patient, while liver biopsy was performed in each patient in the CTPV and cirrhosis groups. The results demonstrated that LSM values were significantly lower in the CTPV group (12.5 kPa; range, 6.8‑21.5 kPa) compared with the CHB‑related cirrhosis group (21.0 kPa; range, 15.5‑27.2 kPa; P=0.017). However, this was still higher compared with healthy volunteers (4.9 kPa; range 4.0‑5.8 kPa; P<0.001). In addition, CTPV patients with cirrhosis (17.7 kPa; range, 13.9‑30.8 kPa) exhibited significantly increased LSM values compared with those without cirrhosis (6.4 kPa; range, 5.7‑7.8 kPa; P<0.001). Furthermore, LSM values in CTPV patients without cirrhosis were slightly higher compared with those of healthy volunteers (P=0.003), while no statistically significant difference was observed in LSM between CTPV patients with cirrhosis and CHB‑related cirrhosis group. These findings indicated that LSM values could be used for the differential diagnosis of CTPV patients with or without cirrhosis. However, further validation studies are needed.

View Figures

View References

1	Elsayes KM, Shaaban AM, Rothan SM, Javadi S, Madrazo BL, Castillo RP, Casillas VJ and Menias CO: A comprehensive approach to hepatic vascular disease. Radiographics. 37:813–836. 2017.PubMed/NCBI View Article : Google Scholar
2	Kuy S, Dua A, Rieland J and Cronin DN II: Cavernous transformation of the portal vein. J Vasc Surg. 63(529)2016.PubMed/NCBI View Article : Google Scholar
3	Yonem O and Bayraktar Y: Is portal vein cavernous transformation a component of congenital hepatic fibrosis? World J Gastroenterol. 13:1928–1929. 2007.PubMed/NCBI View Article : Google Scholar
4	Bayraktar Y, Tuncer ZS, Kabukçu A, Uzunalimoğlu B and Ayhan A: Pregnancy complicated by congenital hepatic fibrosis with cavernous transformation of the portal vein: A case report. Am J Obstet Gynecol. 177:459–461. 1997.PubMed/NCBI View Article : Google Scholar
5	Francoz C, Belghiti J, Vilgrain V, Sommacale D, Paradis V, Condat B, Denninger MH, Sauvanet A, Valla D and Durand F: Splanchnic vein thrombosis in candidates for liver transplantation: Usefulness of screening and anticoagulation. Gut. 54:691–697. 2005.PubMed/NCBI View Article : Google Scholar
6	Ma J, Yan Z, Luo J, Liu Q, Wang J and Qiu S: Rational classification of portal vein thrombosis and its clinical significance. PLoS One. 9(e112501)2014.PubMed/NCBI View Article : Google Scholar
7	Vilgrain V, Condat B, Bureau C, Hakimé A, Plessier A, Cazals-Hatem D and Valla DC: Atrophy-hypertrophy complex in patients with cavernous transformation of the portal vein: CT evaluation. Radiology. 241:149–155. 2006.PubMed/NCBI View Article : Google Scholar
8	Intagliata NM, Caldwell SH and Tripodi A: Diagnosis, development, and treatment of portal vein thrombosis in patients with and without cirrhosis. Gastroenterology. 156:1582–1599.e1. 2019.PubMed/NCBI View Article : Google Scholar
9	Friedrich-Rust M, Poynard T and Castera L: Critical comparison of elastography methods to assess chronic liver disease. Nat Rev Gastroenterol Hepatol. 13:402–411. 2016.PubMed/NCBI View Article : Google Scholar
10	de Franchis R and Faculty BV: Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 53:762–768. 2010.PubMed/NCBI View Article : Google Scholar
11	Bonino F, Arena U, Brunetto MR, Coco B, Fraquelli M, Oliveri F, Pinzani M, Prati D, Rigamonti C, Vizzuti F, et al: Liver stiffness, a non-invasive marker of liver disease: A core study group report. Antivir Ther. 15 (Suppl 3):S69–S78. 2010.PubMed/NCBI View Article : Google Scholar
12	Castera L, Forns X and Alberti A: Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol. 48:835–847. 2008.PubMed/NCBI View Article : Google Scholar
13	Kettaneh A, Marcellin P, Douvin C, Poupon R, Ziol M, Beaugrand M and de Lédinghen V: Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: A prospective study of 935 patients. J Hepatol. 46:628–634. 2007.PubMed/NCBI View Article : Google Scholar
14	Bedossa P and Poynard T: An algorithm for the grading of activity in chronic hepatitis C. The METAVIR cooperative study group. Hepatology. 24:289–293. 1996.PubMed/NCBI View Article : Google Scholar
15	Bosch J, Abraldes JG, Berzigotti A and García-Pagan JC: The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol. 6:573–582. 2009.PubMed/NCBI View Article : Google Scholar
16	Groszmann RJ and Wongcharatrawee S: The hepatic venous pressure gradient: Anything worth doing should be done right. Hepatology. 39:280–282. 2004.PubMed/NCBI View Article : Google Scholar
17	Colecchia A, Montrone L, Scaioli E, Bacchi-Reggiani ML, Colli A, Casazza G, Schiumerini R, Turco L, Biase AR, Mazzella G, et al: Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis. Gastroenterology. 143:646–654. 2012.PubMed/NCBI View Article : Google Scholar
18	European Association for Study of Liver; Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH clinical practice guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 63:237–264. 2015.PubMed/NCBI View Article : Google Scholar
19	Singh S, Muir AJ, Dieterich DT and Falck-Ytter YT: American gastroenterological association institute technical review on the role of elastography in chronic liver diseases. Gastroenterology. 152:1544–1577. 2017.PubMed/NCBI View Article : Google Scholar
20	Sarin SK, Sollano JD, Chawla YK, Amarapurkar D, Hamid S, Hashizume M, Jafri W, Kumar A, Kudo M, Lesmana LA, et al: Consensus on extra-hepatic portal vein obstruction. Liver Int. 26:512–519. 2006.PubMed/NCBI View Article : Google Scholar
21	Gauthier F: Recent concepts regarding extra-hepatic portal hypertension. Semin Pediatr Surg. 14:216–225. 2005.PubMed/NCBI View Article : Google Scholar
22	Sharma P, Mishra SR, Kumar M, Sharma BC and Sarin SK: Liver and spleen stiffness in patients with extrahepatic portal vein obstruction. Radiology. 263:893–899. 2012.PubMed/NCBI View Article : Google Scholar
23	Madhusudhan KS, Sharma R, Kilambi R, Shylendran S, Shalimar Sahni P and Gupta AK: 2D shear wave elastography of liver in patients with primary extrahepatic portal vein obstruction. J Clin Exp Hepatol. 7:23–27. 2017.PubMed/NCBI View Article : Google Scholar
24	de Franchis R and Faculty B VI: Expanding consensus in portal hypertension: Report of the Baveno VI consensus workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol. 63:743–752. 2015.PubMed/NCBI View Article : Google Scholar
25	Rangari M, Gupta R, Jain M, Malhotra V and Sarin SK: Hepatic dysfunction in patients with extrahepatic portal venous obstruction. Liver Int. 23:434–439. 2003.PubMed/NCBI View Article : Google Scholar
26	Huang R, Gao ZH, Tang A, Sebastiani G and Deschenes M: Transient elastography is an unreliable marker of liver fibrosis in patients with portal vein thrombosis. Hepatology. 68:783–785. 2018.PubMed/NCBI View Article : Google Scholar